Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $1.797B (100.0% shares, 0.0% debt)

Holdings (43)

ABIOMED INC 14.5%
Value $261M Shares 2,889,505 Est. Cost $29.48 Unrealized
ANACOR PHARMACEUTICALS INC 13.8%
Value $247M Shares 2,187,242 Est. Cost $23.70 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 13.2%
Value $238M Shares 1,518,654 Est. Cost $81.75 Unrealized +78.1%
BMRN BIOMARIN PHARMACEUTICAL INC 7.8%
Value $140M Shares 1,336,847 Est. Cost $73.11 Unrealized +42.7%
CLOVIS ONCOLOGY INC 6.9%
Value $124M Shares 3,547,719 Est. Cost $57.85 Unrealized
INSM INSMED INC 4.8%
Value $86.95M Shares 4,790,800 Est. Cost $14.79 Unrealized +19.1%
AMAG PHARMACEUTICALS INC 4.8%
Value $85.61M Shares 2,835,792 Est. Cost $30.99 Unrealized
WRIGHT MED GROUP N V 2.9%
Value $51.56M Shares 2,132,157 Est. Cost $24.18 Unrealized
ENDO INTL PLC 2.7%
Value $49.05M Shares 801,230 Est. Cost $89.70 Unrealized
PRTA PROTHENA CORP PLC 2.6%
Value $47.37M Shares 695,518 Est. Cost $22.18 Unrealized +171.9%
EPIZYME INC 2.4%
Value $42.63M Shares 2,660,979 Est. Cost $13.76 Unrealized
KARYOPHARM THERAPEUTICS INC 2.3%
Value $41.24M Shares 3,112,645 Est. Cost $20.94 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.1%
Value $37.53M Shares 4,030,908 Est. Cost $8.48 Unrealized +17.7%
CEMPRA INC 2.0%
Value $36.6M Shares 1,175,733 Est. Cost $31.13 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.9%
Value $34.45M Shares 3,551,173 Est. Cost $5.71 Unrealized +57.8%
CELGENE CORP 1.8%
Value $32.43M Shares 270,800 Est. Cost $97.13 Unrealized
GILD GILEAD SCIENCES INC 1.7%
Value $30.65M Shares 302,900 Est. Cost $63.23 Unrealized +15.3%
MEDIVATION INC 1.4%
Value $24.65M Shares 509,862 Est. Cost $58.10 Unrealized
MOMENTA PHARMACEUTICALS INC 1.2%
Value $21.8M Shares 1,468,776 Est. Cost $14.44 Unrealized
SHIRE PLC 1.2%
Value $21.46M Shares 104,700 Est. Cost $227.87 Unrealized
STAA STAAR SURGICAL CO 1.1%
Value $19.04M Shares 2,666,722 Est. Cost $8.11 Unrealized -0.1%
SEQUENOM INC 0.9%
Value $16.44M Shares 10,023,842 Est. Cost $3.91 Unrealized
ZELTIQ AESTHETICS INC 0.9%
Value $16.37M Shares 573,636 Est. Cost $26.16 Unrealized
RIGEL PHARMACEUTICALS INC 0.9%
Value $15.88M Shares 5,239,119 Est. Cost $3.43 Unrealized
ARIAD PHARMACEUTICALS INC 0.8%
Value $14.11M Shares 2,257,217 Est. Cost $6.81 Unrealized
HEARTWARE INTL INC 0.7%
Value $12.4M Shares 246,068 Est. Cost $87.77 Unrealized
ALIMERA SCIENCES INC 0.4%
Value $7.293M Shares 3,013,793 Est. Cost $4.88 Unrealized
SUNESIS PHARMACEUTICALS INC 0.3%
Value $6.26M Shares 6,974,854 Est. Cost $1.05 Unrealized
AIMMUNE THERAPEUTICS INC 0.3%
Value $6.007M Shares 325,599 Est. Cost $25.32 Unrealized
ACELRX PHARMACEUTICALS INC 0.3%
Value $5.488M Shares 1,425,439 Est. Cost $5.78 Unrealized
IDERA PHARMACEUTICALS INC 0.2%
Value $3.886M Shares 1,257,748 Est. Cost $3.70 Unrealized
EXAS EXACT SCIENCES CORP 0.2%
Value $3.658M Shares 396,276 Est. Cost $12.83 Unrealized -27.5%
DICERNA PHARMACEUTICALS INC 0.2%
Value $3.18M Shares 267,890 Est. Cost $9.72 Unrealized
OREXIGEN THERAPEUTICS INC 0.2%
Value $2.878M Shares 1,673,024 Est. Cost $6.46 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.1%
Value $1.828M Shares 27,757 Est. Cost $53.35 Unrealized +20.3%
ALCOBRA LTD 0.1%
Value $1.596M Shares 254,188 Est. Cost $6.09 Unrealized
HISTOGENICS CORP 0.1%
Value $1.591M Shares 454,545 Est. Cost $11.00 Unrealized
INTREXON CORP 0.1%
Value $1.42M Shares 47,100 Est. Cost $28.82 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.294M Shares 123,686 Est. Cost $6.71 Unrealized +46.1%
SOPHIRIS BIO INC 0.0%
Value $879K Shares 494,000 Est. Cost $2.60 Unrealized
MARINUS PHARMACEUTICALS INC 0.0%
Value $451K Shares 59,017 Est. Cost $8.34 Unrealized
ZOGENIX INC 0.0%
Value $422K Shares 28,600 Est. Cost $13.52 Unrealized
QURE UNIQURE NV 0.0%
Value $338K Shares 20,453 Est. Cost $26.34 Unrealized -29.7%